Bladder cancer is the sixth most common malignancy in the United States and is associated with high morbidity and mortality rates To date, no guidelines have been published that clearly establish bladder cancer management recommendations during the COVID-19 pandemic In this short commentary, we strive to outline recommendations for treatment of both muscle invasive and non-muscle invasive disease based on data from various trials and prior studies while taking into account the potential lack of hospital resources available to physicians depending on their practice location Copyright Â© 2020 - IOS Press and the authors All rights reserved